Skip to main content
Premium Trial:

Request an Annual Quote

GenoSpectra Lands $20M in Second-Round Funding

SAN FRANCISCO, Dec. 19 - Microarray start-up GenoSpectra received $20 million in a second round of private financing, the company said Wednesday.

 

The investment, lead by Seattle, Wash.-based Frazier Healthcare Ventures, included Novartis BioVentures, HBM BioVentures, and the BioMedical Sciences Investment Fund of the Singapore Economic Development Board.

 

GenoSpectra, based in Fremont, Calif., is developing high throughput drug screening and high-density DNA and protein microarrays based on fiber optics technology, which the company said allows the production of relatively inexpensive arrays with massive parallel processing.

 

GenoSpectra was founded in April 2000 and received $5 million in Series A financing in October 2000.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.